V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10324771 | 10042954 | null | 70 | null | 2022-03-31 | 2022-04-07 | Bexarotene | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 100514049 |
| 10331419 | 10042955 | 1.81 | 101 | Palliative (P) | 2017-05-03 | 2017-06-26 | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | 01 | N | FCR | 101328312 |
| 10335464 | 10042957 | 1.67 | 85.2 | Palliative (P) | 2019-03-09 | 2019-03-09 | LORLATINIB | 02 | N | ABEMACICLIB + FULVESTRANT | 100837378 |
| 10336205 | 10042958 | 1.56 | null | Palliative (P) | 2018-06-06 | 2018-07-01 | Cisplatin + Pemetrexed | 02 | N | EC | 101294257 |
| 10337455 | 10042961 | null | null | null | 2021-09-28 | 2021-10-14 | Apalutamide | 02 | null | ABEMACICLIB + FULVESTRANT | 100107589 |
| 10338096 | 10042962 | 1.81 | 87.15 | 03 | 2019-02-18 | 2019-02-18 | EC | 02 | N | ECX | 100994453 |
| 10338436 | 10042963 | 1.66 | null | Palliative (P) | 2019-12-25 | 2020-01-11 | VINORELBINE | 02 | null | SCOPE2 TRIAL | 101338633 |
| 10339046 | 10042964 | 1.6 | 74.8 | Palliative (P) | 2019-03-20 | 2019-06-17 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | IBRUTINIB + RITUXIMAB | 100176934 |
| 10339239 | 10042966 | 0 | 67.5 | Palliative (P) | 2019-03-06 | 2020-02-04 | ABVD | N | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101545721 |
| 10339370 | 10042967 | 1.58 | 88.9 | Adjuvant (A) | 2019-04-26 | 2019-04-26 | Carbo F | 02 | N | DABRAFENIB | 101225592 |
| 10340007 | 10042972 | 1.75 | 57 | Palliative (P) | 2020-02-15 | 2020-02-15 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + OBINUTUZUMAB + VINCRISTINE | 101460337 |
| 10341355 | 10042976 | 1.62 | 57 | null | 2017-04-09 | 2017-04-09 | CAPECITABINE + PACLITAXEL | 02 | null | BRENTUXIMAB | 100889186 |
| 10341785 | 10042977 | 1.84 | 74.1 | Curative (C) | null | 2019-12-13 | Bortezomib + MELPHALAN | N | null | IXAZOMIB + LENALIDOMIDE | 100988540 |
| 10342148 | 10042979 | null | null | Palliative (P) | 2022-05-08 | 2022-05-15 | Cyclophosphamide High Dose | null | null | CISPLATIN + PEMETREXED | 101630061 |
| 10342392 | 10042980 | 1.79 | 60 | Palliative (P) | 2016-06-11 | 2016-06-20 | BMT Fludarabine/Cyclophosphamide/Alemtuzumab | 02 | N | OXALIPLATIN + MDG | 100550491 |
| 10343466 | 10042985 | 1.54 | 82 | Curative (C) | 2020-01-13 | 2020-01-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | IPILIMUMAB | 100303144 |
| 10344794 | 10042987 | 1.85 | 89 | Curative (C) | 2018-04-06 | 2018-04-06 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + RT | 101238011 |
| 10346358 | 10042989 | 1.56 | 108.4 | Palliative (P) | 2019-10-11 | 2019-10-26 | FEC 100 | 02 | N | AML – CYTARABINE | 101808960 |
| 10346604 | 10042990 | 1.7 | 60.8 | Palliative (P) | 2019-12-30 | 2020-01-05 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | null | DACARBAZINE | 100484157 |
| 10346773 | 10042991 | 1.9 | 71.2 | Palliative (P) | 2018-02-09 | 2018-02-09 | Ixazomib + Lenalidomide | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100899835 |
| 10346928 | 10042992 | 1.65 | 70.7 | null | 2021-09-28 | 2021-10-20 | ECX | 02 | null | CAPECITABINE + CARBOPLATIN | 101345310 |
| 10347171 | 10042995 | 1.57 | 79 | Curative (C) | 2016-03-21 | 2019-03-29 | Cetuximab + FLUOROURACIL + OXALIPLATIN | null | N | VINORELBINE | 101200589 |
| 10347418 | 10042999 | 1.83 | 71.3 | Palliative (P) | 2018-10-10 | 2018-10-14 | OSIMERTINIB | N | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100631465 |
| 10347705 | 10043002 | 1.94 | null | 03 | 2019-11-03 | 2019-11-03 | IDELALISIB + RITUXIMAB | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 100880454 |
| 10348598 | 10043005 | 1.75 | null | null | 2018-12-25 | 2018-12-31 | ECX | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 101364972 |
| 10348886 | 10043006 | 1.68 | 85.8 | Palliative (P) | null | 2021-09-24 | BORTEZOMIB + DARATUMUMAB + THALIDOMIDE | N | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101262326 |
| 10349157 | 10043008 | null | 55 | 03 | 2020-03-04 | 2020-03-05 | Nilotinib | 02 | null | LETROZOLE + PALBOCICLIB | 101169428 |
| 10349385 | 10043010 | 1.56 | 96 | Curative (C) | 2020-07-11 | 2020-07-11 | Ipilimumab | N | N | PACLITAXEL + TRASTUZUMAB | 100377680 |
| 10349538 | 10043011 | 1.6 | 70.6 | Palliative (P) | 2019-12-09 | 2019-12-09 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CHLORAMBUCIL + PROCARBAZINE + VINBLASTINE | 101623375 |
| 10349627 | 10043012 | 1.7 | 85.9 | Palliative (P) | 2020-05-12 | 2020-05-12 | Dacarbazine | 02 | null | CARBOPLATIN + PACLITAXEL + PEMBROLIZUMAB | 101436250 |
| 10349649 | 10043013 | null | null | Adjuvant (A) | 2020-04-12 | 2020-04-21 | ABVD | 02 | N | LENVATINIB | 101789148 |
| 10350288 | 10043017 | 1.88 | 88.4 | null | 2020-01-23 | 2020-01-30 | Nilotinib | 02 | null | AZACITIDINE + VENETOCLAX | 100827401 |
| 10354315 | 10043028 | 1.48 | 53.15 | 03 | 2019-02-26 | 2019-03-20 | Cytarabine + Venetoclax | null | N | CARBOPLATIN + EPIRUBICIN + PACLITAXEL | 100951642 |
| 10354321 | 10043029 | 1.73 | 75 | Palliative (P) | 2018-03-06 | 2018-03-06 | Cetuximab + Radiotherapy Load | 02 | N | FEC | 101355376 |
| 10354491 | 10043030 | 0 | 63.6 | Adjuvant (A) | 2018-05-11 | 2018-05-12 | AFATINIB | 02 | N | OCTREOTIDE | 101869239 |
| 10354620 | 10043031 | 1.64 | 68 | Curative (C) | 2020-02-26 | 2020-03-03 | BLEOMYCIN | 02 | Y | FLUOROURACIL + RT | 101595373 |
| 10355987 | 10043034 | 1.63 | 67 | Curative (C) | 2018-11-10 | 2018-11-21 | Apalutamide | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100009399 |
| 10357564 | 10043037 | null | 62 | null | 2018-03-28 | 2018-03-29 | null | 02 | null | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + PROCARBAZINE + VINBLASTINE | 100043286 |
| 10358134 | 10043039 | 1.77 | 0 | null | 2019-12-31 | 2019-12-31 | BENDAMUSTINE + GEMCITABINE + VINORELBINE | 02 | null | ENTRECTINIB | 101767308 |
| 10359844 | 10043042 | 1.47 | 73.8 | Curative (C) | 2019-12-05 | 2019-12-08 | PLATO Trials | 02 | N | CARBOPLATIN + PACLITAXEL + PEMBROLIZUMAB | 101704836 |
| 10360780 | 10043043 | 1.56 | 74.1 | Not known (9) | 2018-07-06 | 2018-07-13 | OSIMERTINIB | N | N | CARBOPLATIN + DOCETAXEL | 100395551 |
| 10360895 | 10043044 | 1.54 | 69.6 | 03 | 2018-06-02 | 2018-06-09 | ANAGRELIDE | 02 | N | SORAFENIB | 101609114 |
| 10362044 | 10043047 | 1.77 | null | null | 2018-12-21 | 2018-12-21 | GEMCITABINE + NAB PACLITAXEL | 2 | N | FLAIR TRIAL | 101165589 |
| 10362620 | 10043049 | 1.68 | null | Palliative (P) | 2019-09-25 | 2019-09-25 | ANAGRELIDE | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101770265 |
| 10364294 | 10043052 | 1.68 | 61.5 | Palliative (P) | 2017-09-14 | 2017-09-16 | AVELUMAB + AXITINIB | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100596677 |
| 10364816 | 10043053 | 1.38 | 97 | Palliative (P) | 2016-02-19 | 2016-02-20 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | null | N | LETROZOLE + PALBOCICLIB | 101317114 |
| 10365447 | 10043054 | 1.77 | 75 | Palliative (P) | 2010-08-14 | 2017-08-01 | CABOZANTINIB | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 101706398 |
| 10365569 | 10043056 | 1.57 | 68 | Curative (C) | 2018-02-05 | 2018-02-05 | STAMPEDE TRIAL | Y | N | LETROZOLE + RIBOCICLIB | 100450528 |
| 10366416 | 10043058 | 1.71 | 78.6 | null | 2018-11-18 | 2018-11-18 | ANAGRELIDE | 02 | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101417409 |
| 10372373 | 10043064 | 1.53 | 72.9 | Curative (C) | 2019-03-12 | 2019-03-12 | Cyclophosphamide Weekly PO | N | N | CARDAMON TRIAL | 100812567 |